Nuclear factor-kappa B activation inhibits proliferation and promotes apoptosis of vascular smooth muscle cells

Area of Science:

• Vascular biology
• Cell signaling
• Molecular mechanisms

Background:

• Vascular smooth muscle cells (VSMCs) play a critical role in cardiovascular health.
• Dysregulation of VSMC proliferation and apoptosis contributes to vascular diseases.
• The role of nuclear factor-kappa B (NF-κB) in VSMC behavior requires further elucidation.

Purpose of the Study:

• To investigate the function of NF-κB in VSMC proliferation and apoptosis.
• To explore the underlying molecular mechanisms of NF-κB action in VSMCs.
• To assess the impact of NF-κB modulation on VSMC behavior.

Main Methods:

• Human aorta VSMCs were utilized and divided into experimental groups including control, NF-κB inhibitor, and NF-κB overexpression.
• Cell proliferation was assessed using the MTT assay.
• Apoptosis was quantified by flow cytometry, and protein expression of NF-κB, FasL, and HRG-1 was determined via Western blotting.

Main Results:

• NF-κB overexpression was successfully achieved and confirmed.
• Activation of NF-κB significantly inhibited VSMC proliferation.
• NF-κB overexpression markedly promoted VSMC apoptosis and upregulated the expression of FasL and HRG-1.

Conclusions:

• Overexpression of NF-κB inhibits VSMC proliferation and induces apoptosis.
• The pro-apoptotic and anti-proliferative effects of NF-κB in VSMCs are potentially mediated by the upregulation of FasL and HRG-1.
• NF-κB represents a potential therapeutic target for vascular diseases characterized by VSMC dysfunction.